COMMUNIQUÉS West-GlobeNewswire

Theratechnologies lance deux campagnes publicitaires aux États-Unis axées vers les usagers potentiels de TROGARZO(MD) et d’EGRIFTA(MD)
20/06/2019
MONTRÉAL, 20 juin 2019 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (Theratechnologies) (TSX: TH) est heureuse d’annoncer le lancement de deux campagnes publicitaires axées vers les usagers potentiels de TROGARZO MD ( [...]
Axovant and Yposkesi Sign Strategic Gene Therapy Development and Manufacturing Partnership
20/06/2019
Partnership secures access to reserved cGMP capacity and resources at Yposkesi for manufacturing to support the global development and commercialization of Axovant’s gene therapy programs BASEL, Switzerland and CORBEIL- [...]
Summit to Present on Pipeline and Strategy for its New Classes of Antibiotics at ASM Microbe 2019
20/06/2019
Summit Therapeutics plc (‘Summit’ or the ‘Company’) Summit to Present on Pipeline and Strategy for its New Classes of Antibiotics at ASM Microbe 2019 Oxford, UK, and Cambridge, MA, US, 20 June 2019 – Summit Therapeutics [...]
Guardion’s Proprietary Medical Device, the MapcatSF®, Receives Patent from the European Union
20/06/2019
San Diego, CA, June 20, 2019 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (“Guardion” or the “Company”) (Nasdaq: GHSI), an ocular health sciences and technologies company that develops, formulates and distributes [...]
Casdin Capital Invests $50 Million in Codexis to Accelerate Strategic Growth Initiatives
20/06/2019
Investment to fund strategic growth initiatives across the diverse and expanding synthetic biology end market REDWOOD CITY, Calif., June 20, 2019 (GLOBE NEWSWIRE) -- Codexis, Inc. (Nasdaq: CDXS), a leading synthetic [...]
Revive Therapeutics Announces Cannabis Product Derivative Manufacturing and Development Facility
20/06/2019
TORONTO, June 20, 2019 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (" Revive " or the " Company ") (TSX VENTURE: RVV) (OTCQB: RVVTF), a specialty cannabis company focused on the research, development, and [...]
The Ensign Group, Inc. Declares Quarterly Dividend of $0.0475 Per Share
20/06/2019
MISSION VIEJO, Calif., June 20, 2019 (GLOBE NEWSWIRE) -- The Ensign Group, Inc. (NASDAQ: ENSG), the parent company of the Ensign™ group of skilled nursing, rehabilitative care services, home health, home care, hospice [...]
Parallax Health Sciences Announces Initiative to Obtain a 510(K) Clearance for its Fotodigm® Enabled Remote Patient Monitoring Platform
20/06/2019
Positions Fotodigm ® to be Issued a CPT Code for Medical Billing SANTA MONICA, CA, June 20, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Parallax Health Sciences, Inc. (OTCQB: PRLX) (''Parallax'' or the ''Company''), an [...]
TeraRecon Receives First-of-Kind FDA Determination
20/06/2019
DURHAM, N.C., June 20, 2019 (GLOBE NEWSWIRE) -- Advanced visualization and artificial intelligence (AI) technology provider, TeraRecon, today announced it has successfully completed an FDA regulatory review of its [...]
AgraFlora Organics Welcomes Collection of Industry Analysts, Institutional Investors and Media Personnel to June 25th Delta Greenhouse Tour; Broadcast To Be Made Available Online Via Corporate Website
20/06/2019
VANCOUVER, British Columbia, June 20, 2019 (GLOBE NEWSWIRE) -- AgraFlora Organics International Inc. (“ AgraFlora ” or the “ Company ”) ( CSE: AGRA) (Frankfurt: PU31) (OTCPK: PUFXF ), a growth oriented and diversified [...]
Innate Pharma to host key opinion leader call on IPH4102 “TELLOMAK” clinical trial design and rationale
20/06/2019
INNATE PHARMA TO HOST KEY OPINION LEADER CALL ON IPH4102 “TELLOMAK” CLINICAL TRIAL DESIGN AND RATIONALE Marseille, France, June 20, 2019, 07:00 AM CEST Innate Pharma SA (the “Company” - Euronext Paris: FR0010331421 – [...]
Innate Pharma organise une conférence téléphonique avec un expert sur le rationnel et le design de l’essai « TELLOMAK » d’IPH4102
20/06/2019
INNATE PHARMA ORGANISE UNE CONFÉRENCE TÉLÉPHONIQUE AVEC UN EXPERT SUR LE RATIONNEL ET LE DESIGN DE L’ESSAI « TELLOMAK » D’IPH4102 Marseille, 20 juin 2019, 07h00 Innate Pharma SA (la « Société » - Euronext Paris : [...]
Addex Shareholders Approve All Resolutions at Annual General Meeting
20/06/2019
Geneva, Switzerland, 20 June 2019 – Addex Therapeutics (SIX: ADXN), a leading company pioneering allosteric modulation-based drug discovery and development, announced today that its shareholders approved with a very [...]
Genocea Announces Pricing of $36,750,000 Public Offering of Common Stock
20/06/2019
CAMBRIDGE, Mass., June 19, 2019 (GLOBE NEWSWIRE) -- Genocea Biosciences, Inc . (NASDAQ: GNCA), a biopharmaceutical company developing personalized cancer immunotherapies, today announced the pricing of its previously [...]
Atreca Announces Pricing of Initial Public Offering
20/06/2019
REDWOOD CITY, Calif., June 19, 2019 (GLOBE NEWSWIRE) -- Atreca, Inc. (Nasdaq: BCEL), a biopharmaceutical company utilizing its differentiated platform to discover and develop novel antibody-based immunotherapeutics to [...]
Cronos Group Inc. Announces Results of Vote for Election of Directors
20/06/2019
TORONTO, June 19, 2019 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“ Cronos Group ” or the “ Company ”) reports that at its Annual Meeting of Shareholders on June 19, 2019 there were 610 [...]
Scholar Rock Announces Pricing of Public Offering of Common Stock
20/06/2019
CAMBRIDGE, Mass., June 19, 2019 (GLOBE NEWSWIRE) -- Scholar Rock Holding Corporation (Nasdaq: SRRK), a clinical-stage biopharmaceutical company focused on the treatment of serious diseases in which protein growth [...]
North Bud Farms Closes First Tranche of Private Placement Financing
19/06/2019
Insider of NORTHBUD Invests $1 Million as Lead Order THIS NEWS RELEASE IS INTENDED FOR DISTRIBUTION IN CANADA ONLY AND IS NOT INTENDED FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED [...]
Optinose Named a 2019 Best Place to Work by Philadelphia Business Journal
19/06/2019
YARDLEY, Pa., June 19, 2019 (GLOBE NEWSWIRE) -- Optinose (NASDAQ:OPTN), a pharmaceutical company focused on patients treated by ear, nose and throat (ENT) and allergy specialists, today announced that the Company has [...]

Pages